Interestingly, absence of CD11c+CD40+ cells did reduce hepatic inflammation during NASH, indicating that CD11c+CD40+ cells have a strong (lipid driven) immune-modulatory function. This evidence concerns the gene ITGAX and metabolic dysfunction-associated steatohepatitis.